0 items USD 0.00Search
Your search for "delveinsight chronic myelocytic leukemia cml chronic myeloid leukemia global api manufacturers 0" gave back 319394 results.
Tioguanine, also known as thioguanine or 6-thioguanine (6-TG) is a medication used to treat acute myeloid leukemia (AML), acute lymphocytic leukemia...
Catalog:
LPI
January 2023
Price: USD 3,660.00
Tioguanine, also known as thioguanine or 6-thioguanine (6-TG) is a medication used to treat acute myeloid leukemia (AML), acute lymphocytic leukemia...
Catalog:
GIR
February 2023
Price: USD 3,480.00
Tioguanine, also known as thioguanine or 6-thioguanine (6-TG) is a medication used to treat acute myeloid leukemia (AML), acute lymphocytic leukemia...
Catalog:
MRRPB5
January 2023
Price: USD 2,900.00
Tioguanine, also known as thioguanine or 6-thioguanine (6-TG) is a medication used to treat acute myeloid leukemia (AML), acute lymphocytic leukemia...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Dasatinib is a selective tyrosine kinase receptor inhibitor that is used in the therapy of chronic myelogenous leukemia (CML) positive for the...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Dasatinib is a selective tyrosine kinase receptor inhibitor that is used in the therapy of chronic myelogenous leukemia (CML) positive for the...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
Summary Publisher estimates that the PEGylated Proteins market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025, and with a...
Catalog:
HYR
May 2021
Price: USD 2,000.00
Dasatinib is a selective tyrosine kinase receptor inhibitor that is used in the therapy of chronic myelogenous leukemia (CML) positive for the...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
It is used in the treatment of cancer. The global Aclacinomycin A (Aclarubicin) API market is projected to reach US$ million in 2029, increasing from...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Inhibition of dihydroorotate dehydrogenase (DHODH), a key enzyme in the de novo pyrimidine synthesis pathway, was recently reported to induce...
Catalog:
MRRPB5
November 2023
Price: USD 2,900.00
Inhibition of dihydroorotate dehydrogenase (DHODH), a key enzyme in the de novo pyrimidine synthesis pathway, was recently reported to induce...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Inhibition of dihydroorotate dehydrogenase (DHODH), a key enzyme in the de novo pyrimidine synthesis pathway, was recently reported to induce...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Asparaginase is an enzyme, as a medication it is used to treat acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-Hodgkin...
Catalog:
9Dimen Research
May 2020
Price: USD 2,850.00
Inhibition of dihydroorotate dehydrogenase (DHODH), a key enzyme in the de novo pyrimidine synthesis pathway, was recently reported to induce...
Catalog:
GIR
February 2023
Price: USD 3,480.00
Venetoclax(CAS：1257044-40-8) is an oral selective BCL-2 inhibitor and antineoplastic agent used in the therapy of refractory chronic lymphocytic...
Catalog:
LPI
February 2023
Price: USD 3,660.00
